High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP - Concepedia

Concepedia

Publication | Open Access

High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP

DOI Full Paper Access

13

Citations

32

References

2024

Year

Sukanya Dhar, Mohona Chakravarti, Nilanjan Ganguly, Akata Saha, Shayani Dasgupta, Saurav Bera, Anirban Sarkar, Kamalika Roy, Juhina Das, Avishek Bhuniya,

Frontiers in Immunology

Abstract

Our data suggests that screening patients for high titre of M-MDSCs might be considered as a new potential biomarker and treatment modality in overcoming chemo-resistance in NHL patients.

References

	Year	Citations

Page 1